Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$789,646
+$93,244 QoQ
Shares Held
3,138
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#2,773
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICUS CAPITAL holds $5,105,271 across 9 Drug Manufacturers - General names. ABBV ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,876 | $1,238,357 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
3,138 | $789,646 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,836 | $749,926 | |
| 4 | LLY |
ELI LILLY & Co
|
584 | $700,467 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,416 | $431,577 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,303 | $363,178 | |
| 7 | NVS |
Novartis AG
|
2,251 | $352,776 | |
| 8 | AMGN |
Amgen Inc
|
716 | $259,277 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $789,646 | 3,138 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $696,402 | 3,202 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $829,190 | 3,629 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $921,992 | 3,982 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $725,588 | 3,909 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $655,797 | 3,130 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $501,647 | 2,823 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $660,965 | 3,347 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $517,132 | 3,015 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $414,641 | 2,277 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $413,769 | 2,670 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $523,945 | 3,515 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $458,082 | 3,400 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $749,198 | 4,701 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $951,882 | 5,890 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,032,074 | 7,690 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,049,605 | 6,853 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $992,437 | 6,122 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $835,147 | 6,168 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $681,786 | 6,300 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $670,437 | 6,257 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $600,166 | 6,852 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $662,027 | 6,743 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $471,692 | 6,191 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||